Torque3 is developing a neurorehabilitation solution that has shown in early testing to result in significantly better recovery outcomes.
A wealth of research over the last 30 years has strongly indicated that stroke recovery can be significantly improved through immersive stimulation and robotic assistance.
The Torque3 system leverages this research with an approach of uncompromising design and implementation combining a robotic chair and virtual reality.
In this episode, Founder/CEO David Ellzey shares some of the science behind Torque3 and insights into where they are headed.
Fluo Labs, Inc. is a premarket clinical stage medical device company pursuing innovative technology to provide drug-free relief of nasal allergy (i.e. hay fever)...
Hall Venture Partners is located at a state-of-the-art Hall Labs innovation campus in Provo, Utah. Hall Venture Partners was established to address the growing...
Ai Medica makes it easy to create clinical and economic value from EHR data using evidence based medicine. They have built a platform on...
